Literature DB >> 23849883

Varenicline modulates spatial working memory deficits in smokers with schizophrenia.

Victoria C Wing, Caroline E Wass, Ingrid Bacher, Rachel A Rabin, Tony P George.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23849883     DOI： 10.1016/j.schres.2013.06.032

Source DB:  PubMed          Journal:  Schizophr Res        ISSN： 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  9 in total

Review 1.  Nicotinic ACh receptors as therapeutic targets in CNS disorders.

Authors:  Kelly T Dineley; Anshul A Pandya; Jerrel L Yakel
Journal:  Trends Pharmacol Sci       Date:  2015-01-29       Impact factor: 14.819

2.  Predictors of tobacco abstinence in outpatient smokers with schizophrenia or bipolar disorder treated with varenicline and cognitive behavioral smoking cessation therapy.

Authors:  Randi M Schuster; Corinne Cather; Gladys N Pachas; Haiyue Zhang; Kristina M Cieslak; Susanne S Hoeppner; David Schoenfeld; A Eden Evins
Journal:  Addict Behav       Date:  2017-02-24       Impact factor: 3.913

3.  Reduced Short-Latency Afferent Inhibition in Prefrontal but not Motor Cortex and Its Association With Executive Function in Schizophrenia: A Combined TMS-EEG Study.

Authors:  Yoshihiro Noda; Mera S Barr; Reza Zomorrodi; Robin F H Cash; Tarek K Rajji; Faranak Farzan; Robert Chen; Tony P George; Zafiris J Daskalakis; Daniel M Blumberger
Journal:  Schizophr Bull       Date:  2018-01-13       Impact factor: 9.306

4.  Measuring cigarette smoking-induced cortical dopamine release: A [¹¹C]FLB-457 PET study.

Authors:  Victoria C Wing; Doris E Payer; Sylvain Houle; Tony P George; Isabelle Boileau
Journal:  Neuropsychopharmacology       Date:  2014-12-15       Impact factor: 7.853

5.  The duplicated α7 subunits assemble and form functional nicotinic receptors with the full-length α7.

Authors:  Ying Wang; Cheng Xiao; Tim Indersmitten; Robert Freedman; Sherry Leonard; Henry A Lester
Journal:  J Biol Chem       Date:  2014-07-23       Impact factor: 5.157

Review 6.  nAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives.

Authors:  Vinay Parikh; Munir Gunes Kutlu; Thomas J Gould
Journal:  Schizophr Res       Date:  2016-01-21       Impact factor: 4.939

7.  Pharmacotherapy of Co-Occurring Schizophrenia and Substance Use Disorders.

Authors:  Sarah C Akerman; Mary F Brunette; Douglas L Noordsy; Alan I Green
Journal:  Curr Addict Rep       Date:  2014-09-27

Review 8.  Effect of Pharmacological Interventions on the Fronto-Cingulo-Parietal Cognitive Control Network in Psychiatric Disorders: A Transdiagnostic Systematic Review of fMRI Studies.

Authors:  Thérèse van Amelsvoort; Dennis Hernaus
Journal:  Front Psychiatry       Date:  2016-05-18       Impact factor: 4.157

9.  Varenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia: A Double-Blind Randomized Trial.

Authors:  Robert C Smith; Revital Amiaz; Tian-Mei Si; Lawrence Maayan; Hua Jin; Sylvia Boules; Henry Sershen; Chunbo Li; Juanjuan Ren; Yanhong Liu; Mary Youseff; Abel Lajtha; Alessandro Guidotti; Mark Weiser; John M Davis
Journal:  PLoS One       Date:  2016-01-05       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.